文献速递关节外科

全因与并发症特异性再入院在全膝关节置换术后

All-Cause Versus Complication-Specific Readmission Following Total Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

基于纽约州SPARCS数据库1997至2014年377705例初次全膝关节置换术患者,30天内全因再入院率为5.8%,其中仅11%为CMS认定的TKA相关并发症,31%为基于专家意见扩展列表的TKA特异性并发症。年龄>85岁、男性、黑人种族、医疗补助保险及合并症与TKA特异性再入院风险相关,医院年手术量极低(<90例)与再入院风险升高相关。

要点

  • 30天内全因再入院率为5.8%,医院中位率为3.9%(四分位距1.1%至7.2%)。
  • 仅11%的全因再入院为CMS认定的TKA相关并发症,31%为专家意见扩展列表的TKA特异性并发症。
  • 年龄>85岁、男性、黑人种族、医疗补助保险及合并症与TKA特异性再入院风险相关。

核心结论

  • TKA特异性并发症的再入院频率相对于全因再入院频率较低。
  • 再入院原因涉及多因素,可能不适合简单干预。
  • 医疗质量再入院率测量应基于手术特异性标准进行计算和风险调整。

研究设计与样本

  • 使用纽约州卫生局SPARCS数据库识别1997至2014年间377705例初次全膝关节置换术患者。
  • 通过ICD-9-CM编码确定术前诊断、合并症和术后并发症。
  • 再入院定义为全因、CMS认定为TKA特异性并发症或基于专家意见扩展列表的TKA特异性并发症。
  • 采用多变量逻辑回归分析确定术后30天内再入院的独立预测因素。
  • 证据等级为治疗性IV级。

主要发现

  • 30天内全因再入院22076例,率为5.8%,医院中位率为3.9%(四分位距[Q1,Q3]=1.1%,7.2%)。
  • 全因再入院中仅11%(占所有TKA的0.7%)为CMS认定的TKA相关并发症,31%(占所有TKA的1.8%)为专家意见扩展列表的TKA特异性并发症。
  • 基于扩展列表的TKA特异性再入院风险因素包括年龄>85岁(OR=1.32,95%CI=1.15至1.52)、男性(OR=1.41,95%CI=1.34至1.49)、黑人种族(OR=1.24,95%CI=1.14至1.34)、医疗补助保险(OR=1.40,95%CI=1.26至1.57)及合并症。
  • 多种合并症与全因再入院风险相关,但与TKA特异性再入院风险不相关。
  • 医院年手术量极低(<90例/年)与再入院风险升高相关。

关键数值与推荐

  • TKA特异性再入院基于CMS认定标准或基于专家意见的扩展列表标准。
  • 年龄>85岁OR=1.32(95%CI=1.15至1.52),男性OR=1.41(95%CI=1.34至1.49),黑人种族OR=1.24(95%CI=1.14至1.34),医疗补助保险OR=1.40(95%CI=1.26至1.57)。
  • 医院年手术量<90例与再入院风险升高相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unplanned readmissions have become an important quality indicator, particularly for reimbursement; thus, accurate assessment of readmission frequency and risk factors for readmission is critical. The purpose of this study was to determine (1) the frequency of and (2) risk factors for readmissions for all causes or procedure-specific complications within 30 days after total knee arthroplasty (TKA) as well as (3) the association between hospital volume and readmission rate. METHODS: The Statewide Planning and Research Cooperative System (SPARCS) database from the New York State Department of Health was used to identify 377,705 patients who had undergone primary TKA in the period from 1997 to 2014. Preoperative diagnoses, comorbidities, and postoperative complications were determined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Readmission was defined as all-cause, due to complications considered by the Centers for Medicare & Medicaid Services (CMS) to be TKA-specific, or due to an expanded list of TKA-specific complications based on expert opinion. Multivariable logistic regression analysis was utilized to determine the independent predictors of readmission within 30 days after surgery. RESULTS: There were 22,076 all-cause readmissions-a rate of 5.8%, with a median rate of 3.9% (interquartile range [Q1, Q3] = 1.1%, 7.2%]) among the hospitals-within 30 days after discharge. Of these, only 11% (0.7% of all TKAs) were due to complications considered to be TKA-related by the CMS whereas 31% (1.8% of all TKAs) were due to TKA-specific complications on the expanded list based on expert opinion. Risk factors for TKA-specific readmissions based on the expanded list of criteria included an age of >85 years (odds ratio [OR] = 1.32, 95% confidence interval [CI] = 1.15 to 1.52), male sex (OR = 1.41, 95% CI = 1.34 to 1.49), black race (OR = 1.24, 95% CI = 1.14 to 1.34), Medicaid coverage (OR = 1.40, 95% CI = 1.26 to 1.57), and comorbidities. Several comorbid conditions contributed to the all-cause but not the TKA-specific readmission risk. Very low hospital volume (<90 cases per year) was associated with a higher readmission risk. CONCLUSIONS: The frequency of readmissions for TKA-specific complications was low relative to the frequency of all-cause readmissions. Reasons for hospital readmission are multifactorial and may not be amenable to simple interventions. Health-care-quality measurement of readmission rates should be calculated and risk-adjusted on the basis of procedure-specific criteria. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. D'Apuzzo M, Westrich G, Hidaka C, et al. All-Cause Versus Complication-Specific Readmission Following Total Knee Arthroplasty. J Bone Joint Surg Am. 2017. PMID: 28678122. doi:10.2106/JBJS.16.00874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。